Why Neubase Therapeutics (NBSE) Shares Are Nosediving
Why Neubase Therapeutics (NBSE) Shares Are Nosediving
Neubase Therapeutics Inc (NASDAQ:NBSE) shares are trading lower by 53% to $0.47 during Tuesday's session after the company on Monday announced it is holding a Special Meeting of Stockholders on May 13, online, to discuss and vote on the proposed liquidation and dissolution of the company, along with an adjournment proposal if necessary.
Neubase Therapeutics Inc（納斯達克股票代碼：NBSE）股價在週二的交易中下跌了53％，至0.47美元，此前該公司週一宣佈將於5月13日在網上舉行股東特別會議，討論和表決該公司的清算和解散提案，必要時還將提出休會提案。
The Board of Directors unanimously recommends voting in favor of these proposals, considering them beneficial for NeuBase and its stockholders. The meeting will be conducted virtually, and stockholders must register by May 12, to attend.
董事會一致建議對這些提案投贊成票，認爲這些提案對NeuBase及其股東有利。會議將以虛擬方式進行，股東必須在5月12日之前註冊才能參加。
It's emphasized that both attending and voting are important, and detailed instructions on how to participate and vote are provided in the accompanying proxy statement. The notice is signed by Todd Branning, Interim Chief Executive Officer and Chief Financial Officer.
有人強調，出席和投票都很重要，隨附的委託書中提供了有關如何參與和投票的詳細說明。該通知由臨時首席執行官兼首席財務官託德·布蘭寧簽署。
Is NBSE A Good Stock To Buy?
NBSE 是一隻值得購買的好股票嗎？
An investor can make a few decisions when deciding whether a stock is a good buy. In addition to valuation metrics and price action which you can find on Benzinga's quote pages – like NeuBase Therapeutics's page for example – there are factors like whether or not a company pays a dividend or buys a large portion of its stock each quarter.
投資者在決定股票是否值得買入時可以做出一些決定。除了可以在Benzinga的報價頁面（例如NeuBase Therapeutics的頁面）上找到的估值指標和價格走勢外，還有一些因素，例如公司是否每季度支付股息或購買大部分股票。
These are known as capital allocation programs. NeuBase Therapeutics does not pay a dividend, but obviously has a few ways it can return value to shareholders. Feel free to search Benzinga's dividend calendar for the next company that is due to pay a dividend and determine what kind of yield you can earn for holding a share of the company.
這些被稱爲資本分配計劃。NeuBase Therapeutics不支付股息，但顯然有幾種方法可以向股東返還價值。您可以隨時在Benzinga的股息日曆中搜索下一家即將派發股息的公司，並確定持有該公司股份可以獲得什麼樣的收益率。
For example, if you're looking to earn an annualized return of 14.97%, you'll need to buy a share of ARMOUR Residential REIT by the Apr. 12, 2024. Once done, you can expect to receive a nominal payout of $0.24 on Apr. 29, 2024.
例如，如果您希望獲得14.97％的年化回報率，則需要在2024年4月12日之前購買ARMOUR住宅房地產投資信託基金的股份。完成後，您預計將在2024年4月29日收到0.24美元的名義補助金。
Buyback programs are obviously different and highly variable. A company can approve a buyback program and purchase shares as it sees fit over the course of time in which the buyback was authorized. Looking through the latest news on NeuBase Therapeutics will often yield whether or not the company has approved a buyback program recently. Buyback programs usually serve as a support for share prices, serving as a backstop for demand.
回購計劃顯然是不同的，而且變化很大。公司可以批准回購計劃，並在回購獲得批准的時間內酌情購買股票。瀏覽NeuBase Therapeutics的最新消息通常可以得出該公司最近是否批准了回購計劃。回購計劃通常作爲股價的支撐，作爲需求的支撐。
According to data from Benzinga Pro, NBSE has a 52-week high of $5.40 and a 52-week low of $0.59.
根據Benzinga Pro的數據，NBSE的52周高點爲5.40美元，52周低點爲0.59美元。